You are here:
Publication details
Selective CHK1 inhibitor MU380 exhibits single-agent activity against chronic lymphocytic leukemia cells with TP53 mutations
Authors | |
---|---|
Year of publication | 2018 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Description | Selective CHK1 inhibitor MU380 exhibits single-agent activity against chronic lymphocytic leukemia cells with TP53 mutations, Selective CHK1 inhibitor MU380 exhibits single-agent activity against chronic lymphocytic leukemia cells with TP53 mutations. |
Related projects: |